NASDAQ Global Select • Healthcare • Biotechnology • US • USD
Quince Therapeutics, Inc. (QNCX) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 2 recommend buying, 5 recommend holding, and 2 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
